Next Investors logo grey

Abundant enhances treatment range with new skin products

Published 19-DEC-2017 13:56 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Abundant Produce (ASX:ABT) has today updated the market regarding its Abundant Natural Health (ANH) brand.

ANH is expanding its Tomato Infused Lycopene skincare treatment range, as foreshadowed in announcements relating to its recent capital raising. Six new products in total will be released in January 2018. The Lycopene range will now include a lip balm and eye cream, with these products coming onto the market in time for the Chinese New Year.

ANH will release Magnesium Sports Spray and Ache Relief Gel under the Body range, as well as Salt Soothing Gel under its Skin range for scaly skin, itchiness and irritation.

“The increased capital has given us the ability to implement a substantially expanded marketing strategy and build brand awareness in Australia and China,” ANH CEO Shanan Birkin said.

“The right product, coupled with impressive packaging and backed by an excellent communications strategy, will bring consumers to ANH and drive future revenue.”

ANH is focused on ramping up customer engagement via digital marketing channels, including social media.

Marketing manager, Claire Woods commented: “Getting our product to the consumer requires an understanding of how consumers are informing themselves, and the trend is Facebook and Instagram. ANH now has over 1200 followers, compared with less than 50 only a month ago.”

At the same time, it’s worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

Tomato Infusion Lips Alive and Eyes Alive face range

tomato infusion

Source: Abundant Natural Health

ANH’s Lycopene Face range now includes Tomato Infusion Face Revive, Lips Alive and Eyes Alive. All of these use ActiveLyco (trademark pending), which is lycopene supercritical-fluid-extracted from the company’s own tomatoes, purpose-bred and grown at Sydney University’s Plant Breeding Institute.

“We’re particularly excited about the potential for the eye cream to drive ANH Face range awareness and sales,” Birkin said.

“Eye products are the largest segment of the global facial cream market. Our products reduce multiple signs of eye aging such as fine lines, wrinkles, puffiness, dryness, and uneven skin tone, and can be applied on the go, giving them an edge over regular eye care products.”

Consumer awareness and concerns around the toxicity of eye product ingredients are driving increased demand for products containing natural ingredients. ActiveLyco uses cold-pressed, low-temperature supercritical fluid extraction processes to preserve delicate botanical structures, avoiding oxidation and keeping the active ingredients ‘alive’ so that they can protect and restore ageing skin.

Cucumber Infusion Magnesium Sports Spray and Ache Relief Gel

abundant produce sports spray

Source: Abundant Natural Health

ANH’s dual-action sports spray and gel deliver high concentrations of magnesium and cucumber extracts to affected areas, reducing the impact of pain and cramps.

Cucumber lactic acids help to draw much-needed fluid to the muscle, while the magnesium assists in the recovery of muscles experiencing soreness, fatigue and deep ache.

Cucumber Infusion Salt Soothing Gel

abundant produce cucumber gel

Source: Abundant Natural Health

This cucumber and salt infused gel can be used to assist with the treatment of psoriasis. ANH executive director, Tony Crimmins, said that he has had psoriasis himself for 30 years, having spent over $300,000 in search of relief with no results — until he began using Salt Soothing Gel.

“I have always found that an ocean swim resulted in better skin for a few days,” Crimmins said.

“Now you can keep a bottle of the beach in your bathroom, combined with cucumber extracts to keep your skin moisturised.”

According to Transparency Market Research independent experts, the global market for psoriasis treatment was worth US$7.8 billion in 2015, and is expected to expand at a 5.1 percent compound annual growth rate (CAGR) during the period from 2016 to 2024, by which time it will surge to US$12.1 billion.

ANH’s new products will be available in January 2018, and the company will announce online purchase availability via its newsletter and social media.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.